# Paper Scout scholarly-quality report - 2026-09-16

> Advisory automated assessment. Relevance and scholarly quality are independent, and human review remains necessary.

## Summary

- Papers assessed or reused: 1
- Scientific quality statuses: uncertain: 1
- Publication statuses: preprint: 1
- Repository-only manuscripts inspected: 0
- Assessment scopes: full_text: 1
- Confidence: medium: 1
- Recommendations: promising: 1
- Score distribution: 70-79: 1
- Assessor types: llm: 1
- Papers downranked: 0
- Papers hidden: 0
- Assessments with score caps: 0
- Assessment failures: 0
- Extraction failures: 0
- Cache hits / misses: 1 / 0
- Assessment version: `quality-evidence-v1`
- Rubric version: `scholarly-rubric-v1`

## Per-paper assessment

### `doi:10.64898/2026.09.03.749176`

- Scientific quality: uncertain
- Rationale: Evidence references failed manuscript-context validation; the proposed scientific judgment is withheld pending review.
- Uncertainty: The paper's central claims about AI framework failures depend on the authors' inspection of intermediate files and run logs that are not fully reproduced in the supplied text. Some quantitative comparisons (e.g., Table 2 reference values) are presented as averages without full underlying data. The paper is a preprint and has not been peer-reviewed. These factors introduce some uncertainty about the reproducibility of the specific failure claims, but the overall pattern is well-documented.
- Manuscript evidence assessed: True; source: https://www.biorxiv.org/content/biorxiv/early/2026/09/07/2026.09.03.749176.full.pdf
- Automated score: 78
- Recommendation: promising
- Confidence / scope: medium / full_text
- Paper type: empirical_research
- Summary: This is an empirical evaluation study comparing five AI research frameworks on two biopharmaceutical tasks. The contribution is clearly stated: extending prior work to test whether AI frameworks can reproduce published antibody developability and lipid-RNA MD studies. The methodology is explicit (full vs. smaller-scope prompts, multiple runs, comparison to reference papers), and the central claims are supported by detailed evidence including tables of run-level results, specific failure examples, and hallucination documentation. The paper appropriately positions itself relative to Paper I and the broader AI-for-science literature. Limitations are acknowledged (e.g., frameworks run in Jan-Mar 2026, computational constraints). The main weakness is that some claims rely on the authors' inspection of intermediate files without those files being supplied, but the manuscript provides sufficient internal evidence for its conclusions.
- Main concerns: The paper's reproducibility is limited by the fact that intermediate AI files and run logs are not fully provided, and some quantitative comparisons rely on the authors' inspection.
- Positive signals: The paper provides novel empirical evidence that current AI research frameworks fail to match the scope and depth of published human studies, including specific new failure modes such as silent reversion of chemical modifications and fabricated simulation claims.; The study uses a systematic evaluation design with full-sized and smaller-scope prompts, multiple independent runs per framework, and comparison to reference papers.
